相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pre-clinical and Clinical Implications of Inside-Out vs. Outside-In Paradigms in Multiple Sclerosis Etiopathogenesis
Haley E. Titus et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
Jose M. Vega-Riquer et al.
CURRENT NEUROPHARMACOLOGY (2019)
Apolipoprotein D Upregulation in Alzheimer's Disease but Not Frontotemporal Dementia
Surabhi Bhatia et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
Extracellular Vesicles Secreted by Astroglial Cells Transport Apolipoprotein D to Neurons and Mediate Neuronal Survival Upon Oxidative Stress
Raquel Pascua-Maestro et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Myelin extracellular leaflet compaction requires apolipoprotein D membrane management to optimize lysosomal-dependent recycling and glycocalyx removal
Nadia Garcia-Mateo et al.
GLIA (2018)
Identification of a novel tetrameric structure for human apolipoprotein-D
Claudia S. Kielkopf et al.
JOURNAL OF STRUCTURAL BIOLOGY (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Biochemically altered myelin triggers autoimmune demyelination
Andrew V. Caprariello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Apolipoprotein D Concentration in Human Plasma during Aging and in Parkinson's Disease: A Cross-Sectional Study
Andreas Waldner et al.
PARKINSONS DISEASE (2018)
Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions
Ana Navarro et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Jorge Correale et al.
BRAIN (2017)
Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice
Ouafa Najyb et al.
MOLECULAR NEUROBIOLOGY (2017)
Protecting cells by protecting their vulnerable lysosomes: Identification of a new mechanism for preserving lysosomal functional integrity upon oxidative stress
Raquel Pascua-Maestro et al.
PLOS GENETICS (2017)
Oxidative stress in multiple sclerosis: Central and peripheral mode of action
Kim Ohl et al.
EXPERIMENTAL NEUROLOGY (2016)
Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions
Hongyun Li et al.
PLOS ONE (2016)
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
Saskia M. Leibowitz et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Animal models of Multiple Sclerosis
Claudio Procaccini et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Aging without Apolipoprotein D: Molecular and cellular modifications in the hippocampus and cortex
Diego Sanchez et al.
EXPERIMENTAL GERONTOLOGY (2015)
Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder-A nationwide cohort study
Louise Scheen et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Apolipoprotein D Internalization Is a Basigin-dependent Mechanism
Ouafa Najyb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain
Sarah Dassati et al.
NEUROBIOLOGY OF AGING (2014)
The Effect of Cellular Differentiation on HSV-1 Infection of Oligodendrocytic Cells
Raquel Bello-Morales et al.
PLOS ONE (2014)
Oxidative Stress Induces Apolipoprotein D Overexpression in Hippocampus during Aging and Alzheimer's Disease
Eva Martinez et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes
Karelle Benardais et al.
NEUROTOXICITY RESEARCH (2013)
Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
Daniel Ontaneda et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease
Surabhi Bhatia et al.
BIOCHEMICAL JOURNAL (2012)
Amyloid-beta(25-35) Induces Apolipoprotein D Synthesis and Growth Arrest in HT22 Hippocampal Cells
Eva Martinez et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Will the real multiple sclerosis please stand up?
Peter K. Stys et al.
NATURE REVIEWS NEUROSCIENCE (2012)
The evidence for a role of B cells in multiple sclerosis
G. Disanto et al.
NEUROLOGY (2012)
Molecular Dynamics Analysis of Apolipoprotein-D - Lipid Hydroperoxide Interactions: Mechanism for Selective Oxidation of Met-93
Aaron J. Oakley et al.
PLOS ONE (2012)
Apolipoprotein D Mediates Autocrine Protection of Astrocytes and Controls Their Reactivity Level, Contributing to the Functional Maintenance of Paraquat-Challenged Dopaminergic Systems
Raquel Bajo-Graneras et al.
GLIA (2011)
Antioxidant activities of recombinant amphioxus (Branchiostoma belcheri) apolipoprotein D
Yu Zhang et al.
MOLECULAR BIOLOGY REPORTS (2011)
Axonal Damage in Multiple Sclerosis
Jeffery D. Haines et al.
MOUNT SINAI JOURNAL OF MEDICINE (2011)
Death receptor signalling in central nervous system inflammation and demyelination
Conor Mc Guire et al.
TRENDS IN NEUROSCIENCES (2011)
Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan
Ana Navarro et al.
AGE (2010)
Apolipoprotein D An overview of its role in aging and age-related diseases
Julien Muffat et al.
CELL CYCLE (2010)
Cuprizone neurotoxicity, copper deficiency and neurodegeneration
Federico Benetti et al.
NEUROTOXICOLOGY (2010)
Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
Marcel P. Stoop et al.
PLOS ONE (2010)
Neuronal injury in chronic CNS inflammation
Eva Zindler et al.
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2010)
Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainate-induced excitotoxic injury
Xin He et al.
NEUROSCIENCE LETTERS (2009)
Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress
Maria D. Ganfornina et al.
AGING CELL (2008)
Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis
Arthur A. Vandenbark et al.
IMMUNOLOGY (2008)
Modulation of apolipoprotein D expression and translocation under specific stress conditions
Sonia Do Carmo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia
L. A. Pasquini et al.
NEUROCHEMICAL RESEARCH (2007)
Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D
Elizabeth A. Thomas et al.
SCHIZOPHRENIA RESEARCH (2007)
Multiple sclerosis: a battle between destruction and repair
Jonathan L. McQualter et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Solubility engineering and crystallization of human apolipoprotein D
A Nasreen et al.
PROTEIN SCIENCE (2006)
Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia
JK Yao et al.
SCHIZOPHRENIA RESEARCH (2005)
Differential expression of apolipoprotein D in human astroglial and oligodendroglial cells
A Navarro et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus
JM Sarjeant et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders
EA Thomas et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome
SP Mahadik et al.
SCHIZOPHRENIA RESEARCH (2002)
Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter
S Do Carmo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy
EA Thomas et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Increased intrathecal production of apolipoprotein D in multiple sclerosis
M Reindl et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Immunocytochemical localization of apolipoprotein D in oligodendrocyte precursor-like cells, perivascular cells, and pericytes in the human cerebral cortex
CY Hu et al.
JOURNAL OF NEUROCYTOLOGY (2001)
Apolipoprotein D
E Rassart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
